Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Sequencing » ASHG: Dutch Nationwide NIPT Implementation Study Sees 42 Percent Uptake After First Year

ASHG: Dutch Nationwide NIPT Implementation Study Sees 42 Percent Uptake After First Year

Oct 22, 2018
|
Julia Karow

NEW YORK (GenomeWeb) – One year after the Netherlands made noninvasive prenatal aneuploidy screening available to all pregnant women as part of a nationwide implementation study, the uptake of the test has been 42 percent, according to a presentation at the American Society of Human Genetics annual meeting in San Diego last week.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

HIV Found in Old Tissue Sample

A tissue sample from the 1960s harbors a near-complete sample of HIV, IFLScience reports.

A New NSF?

A new bill would reshape the US National Science Foundation to include a focus on technological development, according to Science.

Stopped It

The Food and Drug Administration's decision to halt a SARS-CoV-2 study has drawn criticism, according to Stat News.

Genome Biology Papers on Parasite Impacts in Gut, Lung Microenvironment Interactions, More

In Genome Biology this week: features affecting gut microbiome and parasite patterns, cellular interactions in lung tumor microenvironment, and more.

Jun
04
Featured Webinar

COVID-19 Testing, Treatment and Future Outlook

Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

What's Popular?

In Molecular Diagnostics

  1. Head-to-Head Comparisons of Commercial SARS-CoV-2 MDx Tests Point to Few Differences in Accuracy

    Premium

  2. NeoGenomics, Inivata Partner to Commercialize Lung Cancer Liquid Biopsy Test

  3. AstraZeneca, ArcherDx Partner on Minimal Residual Disease Monitoring for Lung Cancer Drug Trials

  4. With Low-Cost SARS-CoV-2 Assay, FYR Diagnostics Looks to Bypass Equipment Bottlenecks

    Premium

  5. Exact Sciences, Express Gene, Avera Institute Get FDA EUAs for Coronavirus Tests

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.